Vascular Therapy and Associated Products 2028

This PME is intended to consult the market and identify potential suppliers capable of meeting the Authority’s emerging requirements for Vascular Therapy products and associated services. Through this engagement, the Authority aims to:

• understand supplier capacity and capability;
• explore opportunities for innovation;
• ensure transparency and awareness of the potential opportunity across the market; and
• inform the design of a future procurement approach that is proportionate, competitive and aligned with NHS Trust requirements.

________________________________________

Understanding current direct routes to market

As part of this PME, the Authority specifically wishes to engage with suppliers to better understand the current direct route to market commercial models operating within the Vascular Therapy category. At present, NHS Supply Chain has limited visibility of how products and services are sold directly to NHS Trusts, including:

• commercial and pricing structures;
• contracting and ordering mechanisms;
• the role of services, training or education within direct sales models; and
• how these arrangements operate in practice for Trusts.

Gaining this insight will support the development of a robust and transparent commercial strategy, inform the design and structure of any future framework arrangement, and help ensure alignment with existing Trust purchasing behaviours and prevailing market practice.

________________________________________

Scope of the Preliminary Market Engagement

The PME will include the following activities:

• Expression of Interest (EOI)

Interested suppliers are invited to submit an Expression of Interest (EOI) via the Jaggaer eProcurement Portal. Interested suppliers can express interest in the opportunity using the following link:

PORTAL ACCESS

• Login with URL nhssupplychain.app.jaggaer.com// ↗
• Click on “SQs Open to All Suppliers” and search for the title of the procurement: Project_1753 - Vascular Therapy and Associated Products 2028 Pre Market Engagement

EXPRESSION OF INTEREST

• Click on the ‘EXPRESS INTEREST’ button in the top right corner.
• Answer the question in the Qualification Envelope.
• The deadline for submission of EOIs is 30 June 2026.
• 1 to 1 Supplier Meetings

Optional 1 to 1 supplier meetings will be offered during June/July 2026 to suppliers who have expressed interest. These sessions will allow for structured discussion on the emerging Vascular Therapy procurement and are expected to cover:

1. Products and specifications
2. Training and educational offerings
3. Supply chain resilience and continuity plans
4. Sustainability requirements
5. Commercial and route‑to‑market models (including direct sales arrangements with NHS Trusts), and any other matters relevant to the potential procurement

• Ongoing Engagement and Feedback

Further engagement meetings may be held to gather feedback on the draft specification and/or product list. This engagement is expected to continue up until the end of August 2026, to support the completion and refinement of requirements.

________________________________________

Draft Documentation and Feedback

• Suppliers who submit an EOI will be provided with draft specifications and a draft product list, which are currently under development.
• This is expected to take place during July–August 2026 (subject to change).
• The Authority will invite feedback, comments and assumptions based on these draft documents to inform the final procurement design.

________________________________________

Nature of Engagement

• The Authority will maintain dialogue with incumbent suppliers and engage with potential new suppliers who express interest, initiating exploratory discussions to understand supplier offerings and assess alignment with emerging requirements.
• Engagement may take place via Microsoft Teams, telephone or face to face meetings, subject to suitability and availability.
• Suppliers who express an interest are encouraged to engage constructively through the engagement opportunities offered as part of this PME.

________________________________________

Important Notices

• This Preliminary Market Engagement does not constitute a commitment by the Authority to commence a formal procurement process or to award any contract(s).

________________________________________

The Authority sincerely appreciates supplier engagement and looks forward to receiving considered input throughout the course of this PME.